Authors:
Antonini, A
Moresco, RM
Gobbo, C
De Notaris, R
Panzacchi, A
Barone, P
Calzetti, S
Negrotti, A
Pezzoli, G
Fazio, F
Citation: A. Antonini et al., The status of dopamine nerve terminals in Parkinson's disease and essential tremor: a PET study with the tracer [11-C]FE-CIT, NEUROL SCI, 22(1), 2001, pp. 47-48
Authors:
Volonte, MA
Moresco, RM
Gobbo, C
Messa, C
Carpinelli, A
Rizzo, G
Comi, G
Fazio, F
Citation: Ma. Volonte et al., A PET study with [11-C]raclopride in Parkinson's disease: preliminary results on the effect of amantadine on the dopaminergic system, NEUROL SCI, 22(1), 2001, pp. 107-108
Authors:
Zanardi, R
Artigas, F
Moresco, R
Colombo, C
Messa, C
Gobbo, C
Smeraldi, E
Fazio, F
Citation: R. Zanardi et al., Increased 5-hydroxytryptamine-2 receptor binding in the frontal cortex of depressed patients responding to paroxetine treatment: A positron emission tomography scan study, J CL PSYCH, 21(1), 2001, pp. 53-58
Authors:
Moresco, RM
Tettamanti, M
Gobbo, C
Del Sole, A
Ravasi, L
Messa, C
Paulesu, E
Lucignani, G
Perani, D
Fazio, F
Citation: Rm. Moresco et al., Acute effect of 3-(4-acetamido)-butyrril-lorazepam (DDS2700) on brain function assessed by PET at rest and during attentive tasks, NUCL MED C, 22(4), 2001, pp. 399-404
Authors:
Moresco, RM
Colombo, C
Fazio, F
Bonfanti, A
Lucignani, G
Messa, C
Gobbo, C
Galli, L
Del Sole, A
Lucca, A
Smeraldi, E
Citation: Rm. Moresco et al., Effects of fluvoxamine treatment on the in vivo binding of [F-18]FESP in drug naive depressed patients: a pet study, NEUROIMAGE, 12(4), 2000, pp. 452-465
Citation: C. Gobbo, Assessing the effects of misinformation on children's recall: How and whenmakes a difference, APPL COGN P, 14(2), 2000, pp. 163-182
Authors:
Moresco, RM
Matarrese, M
Soloviev, D
Simonelli, P
Rigamonti, M
Gobbo, C
Todde, S
Carpinelli, A
Kienle, MG
Citation: Rm. Moresco et al., Synthesis and in vivo evaluation of [C-11]ICI 118551 as a putative subtypeselective beta(2)-adrenergic radioligand, INT J PHARM, 204(1-2), 2000, pp. 101-109